Enzyme Source | Inhibitor | Ki | Inhibition Type |
---|---|---|---|
μM | |||
HLM | NDGA | 13.3 ± 1.5 | Mixed |
Procainamide | 29.3 ± 4.8 | Competitive | |
HLC | NDGA | 2.9 ± 0.5 | Uncompetitive |
Procainamide | 34.5 ± 2.2 | Competitive | |
RLM | Carvedilol | 1.6 ± 0.2 | Competitive |
NDGA | 0.4 ± 0.0 | Uncompetitive | |
RLC | Carvedilol | 2.3 ± 0.3 | Mixed |
NDGA | 0.4 ± 0.0 | Uncompetitive | |
RJM | Carvedilol | 8.8 ± 0.5 | Competitive |
NDGA | 11.0 ± 2.2 | Mixed | |
RJC | Carvedilol | 5.1 ± 1.0 | Competitive |
| NDGA | 3.2 ± 0.3 | Uncompetitive |